What is the Wegovy Pill?
At Birmingham Weight Loss Clinics, we prioritise patient safety, informed choices, and evidence-based treatment options. The Wegovy pill is an oral formulation of semaglutide, the same active ingredient found in the Wegovy injection, but taken as a once-daily tablet rather than a weekly injection. It was approved by the MHRA in June 2026, making it the first GLP-1 receptor agonist tablet licensed in the UK for weight management.
Like its injectable counterpart, the Wegovy pill is not a substitute for lifestyle modification but is intended to support sustainable weight loss alongside behavioural changes.
Please note that this medication may only be prescribed following a full medical consultation by a qualified prescriber, in line with UK legislation and professional standards set by the General Pharmaceutical Council (GPhC).
How the Wegovy Tablet Works
The Wegovy tablet contains semaglutide, which mimics the GLP-1 hormone to help regulate appetite and blood sugar. It works by:
- Reducing hunger signals in the brain
- Slowing digestion, increasing fullness after meals
- Supporting stable blood glucose levels
The tablet must be taken on an empty stomach with a small amount of water, at least 30 minutes before any food, drink, or other medication, to ensure proper absorption.
Wegovy Tablet: Clinical Results
The effectiveness of the Wegovy tablet was established through a 64-week clinical study involving 307 adults living with obesity or overweight with at least one weight-related condition.
Key Results:
- Mean weight loss: 14% of body weight (~33 lb), compared with 2.4% (~6 lb) on placebo
- 76% of participants lost at least 5% of their body weight, compared with 31% on placebo
- Improvements also seen in glycaemic control and cardiometabolic markers
Who Can Take the Wegovy Tablet?
✅ Suitable for adults who:
- Have a BMI ≥30, or ≥27 with a weight-related condition
- Can commit to the required daily dosing routine
- Are not using another GLP-1 medication
❌ Not suitable for those who:
- Are pregnant, breastfeeding, or trying to conceive
- Have a history of MTC, MEN2, or pancreatitis
- Have severe kidney or liver disease
As UK availability is still in early rollout, suitability must be confirmed via consultation. See the NHS guidance on obesity treatment for more.
Frequently Asked Questions
Book a Consultation
For more information and to determine whether the Wegovy tablet is a suitable treatment option for you, please book a consultation with our expert team at Birmingham Weight Loss Clinics.